openPR Logo
Press release

Human Coagulation Factor VII Market Size to Grow Exponentially during 2017 - 2025

01-19-2018 04:57 AM CET | Health & Medicine

Press release from: TMR - Research Report

/ PR Agency: TMR - Research Report
Human Coagulation Factor VII Market Size to Grow Exponentially

Human coagulation factor VII is a single chain plasma glycoprotein that initiates the process of blood clotting in the coagulation cascade. It belongs to the enzyme serine protease family. Factor VII is produced in the liver and then circulated in the plasma where it comes in contact with the tissue factor, an integral membrane protein. After binding, factor VII is converted into factor VIIa which further initiates the coagulation pathway. A factor VII deficiency (a disorder wherein the body is not able to produce factor VII) leads to a condition where blood is unable to clot, causing excessive and prolonged bleeding after a surgery or injury. This deficiency is either acquired or inherited – the former after birth, which may be a result of the effect of medication or diseases which interfere with the production of factor VII such as liver diseases and vitamin K deficiency. Major symptoms associated with factor VII deficiency are longer duration of bleeding caused by wounds, bleeding joints, bleeding gums, and heavy menstrual periods. Diagnosis is mostly accomplished through lab tests such as factor assay, inhibitor tests, and prothrombin time (PT) to measure the functioning of factors I, II, V, VII, and X.

Read Report Overview: https://www.transparencymarketresearch.com/human-coagulation-factor-vii-market.html

Hemophilia is an inherited medical condition in which the patient’s blood is unable to clot. The symptoms could be mild to severe. In severe cases, patients experience internal bleeding. Treatment of hemophilia is usually in the form of medication for genetically engineered factor VII to prevent and treat prolonged bleeding. The rising incidence of hemophilia is a major driver of the human coagulation factor VII market, apart from initiatives taken by governments to create awareness regarding its prevention and treatment and the advent of new techniques for the development of safer and cost-effective products. Limited awareness in the medical profession and among policy makers about the medical conditions in which human coagulation factors VII can be used is a major restraining factor for this market.

The global human coagulation factor VII market has been categorized based on product type into the following categories: recombinant factor VII and plasma-derived factor VII. The former is anticipated to dominate the market due to the safety and efficiency associated with the use of the recombinant product as compared to plasma-derived factor VII. However, improvements in viral inactivation and advanced screening method have greatly improved the safety aspect of plasma-derived factor VII. In terms of application, the global human coagulation factor VII market has been segmented into the following sections: hemophilia, surgery, and others. Hemophilia is predicted to lead the market, followed by surgery. By end-user, the market has been divided into the following groups: hospitals, ambulatory surgery centers, specialty clinics, and others.

Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=24074

Geographically, the global human coagulation factor VII market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a major market, followed by Europe. The rising number of hemophilia patients, surge in health care expenditure, and increasing awareness about hemophilia created by government organizations in developed countries are factors contributing to the expansion of the market in this region. The hemophilia population in developing countries accounts for about 80% of the global hemophilia population and is projected to emerge as a lucrative market owing to the increasing efforts taken by government organizations to create awareness and the involvement of NGOs to create better health care facilities and educate patients regarding available treatment.

Key players in the global market include Baxter International Inc, Bayer AG, Pfizer Inc., CSL Behring, Grifols USA, LLC, Novo Nordisk, Octapharma AG, ProSpec- Tany Technogene Ltd., Enzyme Research Laboratories, and others.

Pre Book Human Coagulation Factor VII Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=24074<ype=S

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About us:
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Coagulation Factor VII Market Size to Grow Exponentially during 2017 - 2025 here

News-ID: 907825 • Views: 172

More Releases from TMR - Research Report

Global Tissue Extraction System Market: Trends and Opportunities 2017 - 2025
Global Tissue Extraction System Market: Overview The global tissue extraction system market is foretold to display an impressive growth rate in the coming years. This could be owing to the need for tissue extraction or biopsy for cancer analysis after the patient has been suspected of carrying the disease. The procedure is extremely vital for diagnosing the disease. Thus, increasing prevalence of carcinogenic agents, compromised immunity levels, and rising incidence of
Neurology Sterile Injectable Market: Growth Factors, Applications, Regional Anal …
Neurology sterile injectables are generally administered to individuals suffering from pain linked to the nerves. Neuropathic pain injections are used to provide relief to these individuals. Neurology sterile injectable block the pain signal from reaching the brain. Neurological sterile injection can be administered at sympathetic nervous system, trigger points, dorsal roots, and peripheral nerves. The most commonly use neurological injectable used for nerve block are steroid injection, opioids, and local
External Fixator Devices Market: Global Survey and Trend Research
External fixator devices are used to stabilize and support long bone open fractures to help the patient carry body’s weight as well as movement. Schanz screws, connecting rods, and clamps are used in case of unipolar external fixators. Circulatory fixators include circular rings, wires, connecting rods, and struts. The external fixator devices provide rigid fixation along with fixed distraction of the fracture fragments. The major advantage of external fixator devices
Anorectal Preparations Market Trends, and Forecast 2017 - 2025
Anorectal preparations are products that contain a combination of an anti-inflammatory agent, or a pain reliever, and a local anesthetic as a suppository, or an ointment. External or internal hemorrhoids are treated by the topical application of anorectal preparations. Hemorrhoids are masses or lumps of tissue in the anus that contain enlarged blood vessels. The formation of hemorrhoids is due to an increase in abdominal pressure. Frequent constipation, which is

All 5 Releases


More Releases for VII

Human Coagulation Factor VII Market 2020 Demand Analysis – NovoNordisk
Global Human Coagulation Factor VII Market Growth 2020-2025 The report will make detailed analysis mainly on in-depth research on the development environment, Market size, development trend, operation situation and future development trend of Human Coagulation Factor VII Market on the basis of stating current situation of the industry in 2020. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect
Global Human Coagulation Factor VII Sales Market Report 2018| Baxter, Bayer, Pfi …
Albany, NY, 24th July : Recent research and the current scenario as well as future market potential of "Global Human Coagulation Factor VII Sales Market Report 2018" globally. This report studies the global Human Coagulation Factor VII market status and forecast, categorizes the global Human Coagulation Factor VII market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe,
Global Human Coagulation Factor VII Market 2018 - NovoNordisk
Eminent Market, recently published a detailed market research study focused on the "Human Coagulation Factor VII Market" across the global, regional and country level. The report provides 360° analysis of "Human Coagulation Factor VII Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Human Coagulation Factor VII industry, and estimates the future
Human Coagulation Factor VII Market Size, Status and Forecast 2025
Human coagulation factor VII is a single chain plasma glycoprotein that initiates the process of blood clotting in the coagulation cascade. It belongs to the enzymeserine protease family. Factor VII is produced in the liver and then circulated in the plasma where it comes in contact with the tissue factor, an integral membrane protein. After binding, factor VII is converted into factor VIIa which further initiates the coagulation pathway. A
Human Coagulation Factor VII Market 2017 : Startup Strategy Resources, Grow Pric …
The recent report of Market Research Store on the “Human Coagulation Factor VII Market Research” has the complete assessment of the latest trends of the global Human Coagulation Factor VII market. The report focuses on the manufacturing challenges that are being faced and provides the solutions and the strategies that have been implemented to overcome the problems. Deep researches and analysis were done during the preparation of the report. The information
EMG Executive to Speak at CASE District VII Conference
IRVINE, CA – Earthbound Media Group (EMG) announces an upcoming speaking engagement featuring Chief Visionary Officer and Managing Partner Damien Navarro at a track session for the 2008 “Shaping the Future: The New Dimensions of Advancement” CASE District VII Conference. Presenting alongside University of Nevada, Las Vegas (UNLV) Development of Communications Director Lori Bachand, Navarro will cover EMG and UNLV’s collaborative development of a profitable variable data publication (VDP) solution